Literature DB >> 15611084

Phospholipid scramblase 1 contains a nonclassical nuclear localization signal with unique binding site in importin alpha.

Min-Hsuan Chen1, Iris Ben-Efraim, Gregory Mitrousis, Nancy Walker-Kopp, Peter J Sims, Gino Cingolani.   

Abstract

Nuclear import of proteins containing a classical nuclear localization signal (NLS) is an energy-dependent process that requires the heterodimer importin alpha/beta. Three to six basic contiguous arginine/lysine residues characterize a classical NLS and are thought to form a basic patch on the surface of the import cargo. In this study, we have characterized the NLS of phospholipid scramblase 1 (PLSCR1), a lipid-binding protein that enters the nucleus via the nonclassical NLS (257)GKISKHWTGI(266). This import sequence lacks a contiguous stretch of positively charged residues, and it is enriched in hydrophobic residues. We have determined the 2.2 A crystal structure of a complex between the PLSCR1 NLS and the armadillo repeat core of vertebrate importin alpha. Our crystallographic analysis reveals that PLSCR1 NLS binds to armadillo repeats 1-4 of importin alpha, but its interaction partially overlaps the classical NLS binding site. Two PLSCR1 lysines occupy the canonical positions indicated as P2 and P5. Moreover, we present in vivo evidence that the critical lysine at position P2, which is essential in other known NLS sequences, is dispensable in PLSCR1 NLS. Taken together, these data provide insight into a novel nuclear localization signal that presents a distinct motif for binding to importin alpha.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611084     DOI: 10.1074/jbc.M413194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Probing the specificity of binding to the major nuclear localization sequence-binding site of importin-alpha using oriented peptide library screening.

Authors:  Sundy N Y Yang; Agnes A S Takeda; Marcos R M Fontes; Jonathan M Harris; David A Jans; Bostjan Kobe
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

2.  Molecular basis for the recognition of phosphorylated STAT1 by importin alpha5.

Authors:  Jonathan Nardozzi; Nikola Wenta; Noriko Yasuhara; Uwe Vinkemeier; Gino Cingolani
Journal:  J Mol Biol       Date:  2010-07-17       Impact factor: 5.469

Review 3.  Nuclear transport is becoming crystal clear.

Authors:  Alexis S Madrid; Karsten Weis
Journal:  Chromosoma       Date:  2006-01-19       Impact factor: 4.316

4.  Atomic resolution structures in nuclear transport.

Authors:  Katherine E Süel; Ahmet E Cansizoglu; Yuh Min Chook
Journal:  Methods       Date:  2006-08       Impact factor: 3.608

5.  A 24-residue presequence localizes human factor B to mitochondria.

Authors:  Grigory I Belogrudov
Journal:  Arch Biochem Biophys       Date:  2007-02-22       Impact factor: 4.013

Review 6.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

7.  The importin beta binding domain modulates the avidity of importin beta for the nuclear pore complex.

Authors:  Kaylen Lott; Anshul Bhardwaj; Gregory Mitrousis; Nelly Pante; Gino Cingolani
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

Review 8.  Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells.

Authors:  Noel M Rysavy; Lori M N Shimoda; Alyssa M Dixon; Mark Speck; Alexander J Stokes; Helen Turner; Eric Y Umemoto
Journal:  Bioarchitecture       Date:  2014

9.  Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal α-toxin.

Authors:  Miroslaw Lizak; Timur O Yarovinsky
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

Review 10.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.